China Grants First mRNA COVID Vaccine Approval To Homegrown Latecomer
Executive Summary
CSPC Pharmaceutical's SYS6006 has gained an emergency use authorization in China less than one year after entering clinical trials, becoming the first mRNA vaccine for COVID-19 to be approved in the country.